272
Participants
Start Date
April 30, 2012
Primary Completion Date
April 30, 2015
Study Completion Date
October 31, 2016
Ivermectin
Participants are either given Ivermectin alone or Ivermectin in combination with Albendazole
Albendazole
Albendazole will be given to participants in Arm 2 and 3 in combination with Ivermectin at varying time points.
Committee on Human Research Publications and Ethics, Kumasi
Washington University School of Medicine
OTHER
University Hospitals Cleveland Medical Center
OTHER